Skip to content
Home/Companies/MedTech/Vortex Biotech Holdings
Vortex Biotech Holdings

Vortex Biotech Holdings

MedTech·UK·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Vortex Biotech Holdings?

Vortex Biotech Holdings is currently owned by EMV Capital through EMV Capital Evergreen Fund (2012 vintage), since 2019.

Hand-verified · updated 2026-07-17

EMV Capital
Investor
EMV Capital
EMV Capital Evergreen Fund · 2012 · VC

Key facts

HQUK
SectorMedTech
StatusActive
Websitevortexctc.ai

More from EMV Capital Evergreen Fund

Other portfolio companies in the same fund.

Dogtooth Technologies
Active
TMTUK· 2026
AMR Bio
AMR Bio
Active
BiotechUK· 2025
Dname-iT
Active
SoftwareUK· 2023
DeepTech Recycling
DeepTech Recycling
Active
ClimateTechUK· 2022
Ventive
Ventive
Active
TMTUK· 2022
Cetromed
Active
BiotechUK· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Vortex Biotech Holdings

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Vortex Biotech Holdings?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Vortex Biotech Holdings.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue